BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT

$2.70 -3.57% at last close

Financials (TTM)

Trailing-twelve-month financial statements are not available for BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) — this is common for ETFs and funds, which report holdings rather than income statements. See the overview page for price history and key stats.

Key Stats

Last Close
$2.70
Market Cap
$224.49 million
52-Week Range
$2.51 – $14.87
Average Volume
631K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.